The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThrogmorton Trust Regulatory News (THRG)

Share Price Information for Throgmorton Trust (THRG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 606.00
Bid: 606.00
Ask: 607.00
Change: 4.00 (0.66%)
Spread: 1.00 (0.165%)
Open: 599.00
High: 609.00
Low: 599.00
Prev. Close: 602.00
THRG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

30 Dec 2019 15:59

BlackRock Throgmorton Trust Plc - Portfolio Update

BlackRock Throgmorton Trust Plc - Portfolio Update

PR Newswire

London, December 30

BLACKROCK THROGMORTON TRUST PLC (LEI: 5493003B7ETS1JEDPF59) 

All information is at 30 November 2019 and unaudited.Performance at month end is calculated on a cum income basis

One Month %Three months %One year %Three years %Five years %
Net asset value6.88.224.462.1114.3
Share price9.211.542.8109.0161.2
Benchmark*4.26.58.019.141.6

Sources: BlackRock and Datastream

*With effect from 22 March 2018 the Numis Smaller Companies plus AIM (excluding Investment Companies) Index replaced the Numis Smaller Companies excluding AIM (excluding Investment Companies) Index as the Company’s benchmark. The performance of the indices have been blended to reflect this.

At month end
Net asset value capital only:628.10p
Net asset value incl. income:634.09p
Share price640.00p
Discount to cum income NAV0.9%
Net yield1:1.6%
Total Gross assets2:£470.1m
Net market exposure as a % of net asset value3:95.8%
Ordinary shares in issue4:74,130,326
2018 ongoing charges (excluding performance fees)5,6:0.6%
2018 ongoing charges ratio (including performance fees)5,6,7:1.3%

1. Calculated using the 2019 interim dividend declared on 23 July 2019 and paid on 28 August 2019, together with the 2018 final dividend declared on 12 February 2019 and paid on 28 March 2019.

2. Includes current year revenue and excludes gross exposure through contracts for difference.

3. Long exposure less short exposure as a percentage of net asset value.

4. Excluding 6,400,000 shares held in treasury.

5. Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 30 November 2018.

6. With effect from 1 August 2017 the base management fee was reduced from 0.70% to 0.35% of gross assets per annum.

7. Effective 1st December 2017 the annual performance fee is calculated using performance data on an annualised rolling two year basis (previously, one year) and the maximum annual performance fee payable is effectively reduced to 0.90% of two year rolling average month end gross assets (from 1% of average annual gross assets over one year). Additionally, the Company now accrues this fee at a rate of 15% of outperformance (previously 10%). The maximum annual total management fees (comprising the base management fee of 0.35% and a potential performance fee of 0.90%) are therefore 1.25% of average month end gross assets on a two year rolling basis (from 1.70% of average annual gross assets).

Sector Weightings% of Total Assets
Consumer Services26.6
Industrials25.2
Financials18.1
Consumer Goods7.6
Health Care7.1
Technology6.8
Telecommunications2.0
Basic Materials1.2
Oil & Gas0.5
Net current assets 4.9
-----
Total100.0
=====

Market Exposure (Quarterly)
28.02.19 %31.05.19 %31.08.19 %30.11.19 %
Long108.7113.7109.1103.2
Short14.913.211.27.4
Gross exposure123.6126.9120.3110.6
Net exposure93.8100.597.995.8

Ten Largest Investments
Company% of Total Gross Assets
WH Smith3.0
4imprint Group2.9
IntegraFin2.8
YouGov2.8
Workspace Group2.6
Serco Group2.5
Dechra Pharmaceuticals2.5
SSP2.4
Bodycote2.4
Aveva2.0

Commenting on the markets, Dan Whitestone, representing the Investment Manager noted:

During November the Company’s NAV per share rose by 6.8%1 to 634.09p on a cum income basis, whilst our benchmark index, the Numis Smaller Companies plus AIM (excluding Investment Companies) Index, rose by 4.2%1. Performance during the month was driven by holdings within the long book, whilst the short book moderately detracted.

November also marks the end of the Company’s financial year, and we are pleased to announced that the Company returned 24.4%, outperforming our benchmark by 16.4% during the year (on a net basis).

Whilst stock market returns were positive in November and the Company outperformed the benchmark, market conditions remained volatile against a backdrop of the UK General Election and updates on US/China trade negotiations. UK domestic assets in particular performed strongly over the month as sterling rose in response to polling data that leaned towards a Conservative majority in the election.

The largest positive contributor to performance was Bodycote, which saw its share price rise after issuing a positive trading update, highlighting an improving trend on first half performance. Games Workshop, which is best known as the creator of the Warhammer miniatures game, delivered a very strong set of results ahead of expectations and also upgraded their forward guidance. Shares in WH Smith continued to rise in response to the strategic acquisition of Marshall Retail Group (MRG) which was announced during October. Trading at WH Smith remains robust, and the acquisition of MRG is an important step in the company’s expansion into the US market.

The largest detractor to performance during the month was veterinary medicine producer, Eco Animal Health Group, which fell after the company issued a profit warning in response to a sharp slowdown in sales in China, where demand has fallen sharply in response to the African Swine Fever epidemic that has significantly reduced the pig herd and where the impact on revenues was far greater than we had anticipated. The company’s decision to maintain the cost base so they are well placed to benefit from the recovery in demand once the outbreak is contained meant the reduction in revenues had a disproportionate impact on profitability. We have subsequently reduced the position but maintain a holding as we see its long-term competitive position unchanged. Hiscox remained weak after October’s results and Beazley warned of heightened claims activity impacting profitability.

We deliberately reduced the gross and net exposures of the portfolio towards the end of the month, using the recent strength in UK domestic stocks as an opportunity to pare back exposure as we felt a rather asymmetrical risk/reward profile developing for many UK businesses heading into the General Election. This was aimed to protect clients’ capital in the event of an adverse political outcome, and it leaves us in a position to add risk in the event of greater political clarity. The subsequent Conservative majority does remove a tail risk in our view, and more clarity should lead to increased business confidence and corporate spending (something we will look for evidence of in our interactions with company management teams). This has the potential to create a healthy backdrop of improving corporate profitability both for domestic and global facing UK PLCs.

However, before we get too carried away, we would like to remind investors that rather than making knee-jerk decisions in response to recent currency movements, we continue to build the portfolio based on stock and industry specific investment cases and our investment process remains centred around the factors that we think lead to long-term compounding growth for successful companies. Nor do we think the Election outcome will reverse many of the structural issues facing some UK domestic industries. The progress (or lack thereof) of trade talks between the US and China is of far greater significance for the global economy and relevance to many of the portfolio’s holdings, so positive developments here combined with the improving business confidence and spending in the UK (if it materialises) could certainly create an attractive backdrop for our asset class in 2020.

In summary, 2019 has been a successful year for the Company and the outperformance of the benchmark has far exceeded our expectations. We believe this result is evidence for our belief that stock and industry specifics can triumph over macro, particularly during times of uncertainty. We thank shareholders for their support during the year and look forward to the opportunities that 2020 will bring.

1Source: BlackRock as at 30 November 2019

30 December 2019

ENDS

Latest information is available by typing www.blackrock.co.uk/thrg on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
10th May 202412:33 pmPRNNet Asset Value(s)
10th May 20247:00 amPRNTotal Voting Rights
9th May 20245:39 pmPRNTransaction in Own Shares
9th May 202412:08 pmPRNNet Asset Value(s)
8th May 20245:51 pmPRNTransaction in Own Shares
8th May 202412:17 pmPRNNet Asset Value(s)
7th May 202412:32 pmPRNNet Asset Value(s)
7th May 20247:00 amPRNTotal Voting Rights
3rd May 202412:08 pmPRNNet Asset Value(s)
3rd May 20247:00 amPRNTotal Voting Rights
2nd May 20245:50 pmPRNTransaction in Own Shares
2nd May 20245:26 pmPRNDisclosure of Portfolio Holdings
2nd May 202412:06 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 20246:33 pmPRNTransaction in Own Shares
1st May 202412:05 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20245:44 pmPRNTransaction in Own Shares
30th Apr 202412:06 pmPRNNet Asset Value(s)
30th Apr 20247:00 amPRNTotal Voting Rights
29th Apr 20245:51 pmPRNTransaction in Own Shares
29th Apr 20244:59 pmPRNPortfolio Update
29th Apr 202412:24 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 20245:36 pmPRNTransaction in Own Shares
26th Apr 202411:42 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20246:00 pmPRNTransaction in Own Shares
25th Apr 20245:45 pmPRNDirector/PDMR Shareholding
25th Apr 202412:11 pmPRNNet Asset Value(s)
25th Apr 20247:00 amPRNTotal Voting Rights
24th Apr 20245:54 pmPRNTransaction in Own Shares
24th Apr 202412:11 pmPRNNet Asset Value(s)
24th Apr 20247:00 amPRNTotal Voting Rights
23rd Apr 20245:41 pmPRNTransaction in Own Shares
23rd Apr 202412:11 pmPRNNet Asset Value(s)
23rd Apr 20247:00 amPRNTotal Voting Rights
22nd Apr 20245:52 pmPRNTransaction in Own Shares
22nd Apr 202411:52 amPRNNet Asset Value(s)
22nd Apr 20247:00 amPRNTotal Voting Rights
19th Apr 20246:00 pmPRNTransaction in Own Shares
19th Apr 202412:05 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 20246:36 pmPRNTransaction in Own Shares
18th Apr 202412:14 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20245:58 pmPRNTransaction in Own Shares
17th Apr 202412:12 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:45 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.